Trial Profile
A nationwide surveillance of sequential introduction of 7-valent and 13-valent pneumococcal conjugate vaccine in children with invasive pneumococcal disease (IPD)
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 29 Apr 2016
Price :
$35
*
At a glance
- Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary) ; Pneumococcal 7-valent CRM197 vaccine conjugate (Primary)
- Indications Pneumococcal infections
- Focus Therapeutic Use
- 23 Apr 2016 Results published in the Vaccine.
- 30 Dec 2015 New trial record